Comparing the effects of Bupropion and Buprenorphine on the reduction of Methamphetamine craving

Comparing the effects of Bupropion and Buprenorphine on the reduction of craving in Methamphetamine dependent hospitalized patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015010320540N1

Enrollment

Registered

2015-04-10

Start date

2015-01-25

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methamphetamine Dependency. Mental and behavioural disorders due to use of other stimulants, including caffeine : dependence syndrome

Interventions

Intervention 1: Intervention group will receive Buprenorphine 4mg tablets twice a day for 2weeks to 1month. Intervention 2: Control group will receive Bupropion 150mg tablets twice a day for 2weeks to

Treatment - Drugs

Intervention group will receive Buprenorphine 4mg tablets twice a day for 2weeks to 1month.

Control group will receive Bupropion 150mg tablets twice a day for 2weeks to 1month.

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 18 to 50 years old ; Informed Consent ; The main substance is Methamphetamine. Exclusion criteria: Dissatisfaction at the start or anytime during the research ; The main substance is something except Methamphetamine.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Methamphetamine Craving Level. Timepoint: Daily. Method of measurement: Methamohetamine Craving Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactProf .Ali Sahraian

Shiraz University of Medical Sciences, Shiraz, Iran

sahraian@sums.ac.ir+98 71 3230 5884

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 20, 2026